Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Steffel

Showing results (171-180 of 204) with videos related to

Pageof 21
Sort By:
European Journal of Heart Failure|November 19, 2016
Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRTMatthias P Nägele, Jan Steffel, Michele Robertson, et al.
International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.
BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
Plos One|November 14, 2013
A novel electrocardiographic index for the diagnosis of diastolic dysfunctionMehdi Namdar, Patric Biaggi, Barbara Stähli, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical carePaulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
European Heart Journal Open|June 9, 2023
Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AFAlan John Camm, Jan Steffel, Saverio Virdone, et al.
The American Journal of Cardiology|May 6, 2014
Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasiaArdan M Saguner, Sabrina Ganahl, Samuel H Baldinger, et al.
Pacing and Clinical Electrophysiology : PACE|July 8, 2021
Transvenous lead extraction: The influence of age on patient outcomes in the PROMET study cohortZaki Akhtar, Ahmed I Elbatran, Christoph T Starck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2020
First magnetic resonance imaging-guided cardiac radioablation of sustained ventricular tachycardiaMichael Mayinger, Boldizsar Kovacs, Stephanie Tanadini-Lang, et al.
Annals of Medicine|April 5, 2021
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registryMarita Knudsen Pope, Dan Atar, Arne Svilaas, et al.
Pageof 21

Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
European Journal of Heart Failure|November 19, 2016
Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRTMatthias P Nägele, Jan Steffel, Michele Robertson, et al.
International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.
BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
Plos One|November 14, 2013
A novel electrocardiographic index for the diagnosis of diastolic dysfunctionMehdi Namdar, Patric Biaggi, Barbara Stähli, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical carePaulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
European Heart Journal Open|June 9, 2023
Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AFAlan John Camm, Jan Steffel, Saverio Virdone, et al.
The American Journal of Cardiology|May 6, 2014
Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasiaArdan M Saguner, Sabrina Ganahl, Samuel H Baldinger, et al.
Pacing and Clinical Electrophysiology : PACE|July 8, 2021
Transvenous lead extraction: The influence of age on patient outcomes in the PROMET study cohortZaki Akhtar, Ahmed I Elbatran, Christoph T Starck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2020
First magnetic resonance imaging-guided cardiac radioablation of sustained ventricular tachycardiaMichael Mayinger, Boldizsar Kovacs, Stephanie Tanadini-Lang, et al.
Annals of Medicine|April 5, 2021
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registryMarita Knudsen Pope, Dan Atar, Arne Svilaas, et al.
Pageof 21